Dementiaby Joseph Quinn
This book looks at dementia and considers topics including: diagnosis and differential diagnosis of dementia; rapidly progressive dementia and its imitators; young onset dementia; depression and whether it is a cause or complication of cognitive decline; prodromal dementia; using psychotropic medications to manage problem behaviors in dementia; palliative care
This book looks at dementia and considers topics including: diagnosis and differential diagnosis of dementia; rapidly progressive dementia and its imitators; young onset dementia; depression and whether it is a cause or complication of cognitive decline; prodromal dementia; using psychotropic medications to manage problem behaviors in dementia; palliative care in advanced dementias; legal/economic/social issues in dementia; and assessing outcomes in dementia care. Essential reading for neurologists, psychiatrists, and gerontologists.
Description: The diagnosis of dementia encompasses a variety of etiologies, each with potentially distinct prognostic implications for patients and their families. Given the wide range of presentations and the lack of disease-modifying agents for the neurodegenerative subtypes, the initial evaluation and the continuing care of these patients pose numerous challenges to clinicians. The book provides a succinct and clinically applicable review of the management of patients presenting with progressive cognitive impairments. It also discusses ethical considerations, preventive measures, and the latest research findings that are guiding current clinical practice.
Purpose: According to the editors, the purpose is to "meet the request for a brief, practical clinician's guide to dementia." The chapter topics were selected "based on the questions most often referred to us in a memory disorders clinic from practicing neurologists." This is part of the Neurology in Practice series, which is meant to provide physicians with "direct, useful information to help them in clinical care."
Audience: Although the editors of the series indicate the volumes are meant to be "guides to effective patient care for neurologists," this book is appropriate for a much broader audience, including psychiatrists, geriatricians, and other primary care providers who frequently encounter patients with dementia.
Features: The format of the book exemplifies its clinical utility. Chapters begin with the differential diagnosis of dementia and then expand upon the workup of the rapidly progressive and young onset subtypes. Other chapters cover normal pressure hydrocephalus, the complex relationship of depression and dementia, and mild cognitive impairment. The book progresses with chapters on the continuing care of patients with dementia in terms of medication management, palliative care, outcome assessment, and primary prevention. Throughout, helpful boxes, tables, and figures highlight the main principles and summarize key guidelines.
Assessment: This is an excellent overview of the differential diagnosis and treatment of patients with dementia. It provides practical tips to guide clinicians through the initial diagnosis, current treatment options, and long-term complexities of caring for patients with cognitive decline. The information is presented in a clinically relevant and concise manner. With further advances in neuroimaging, disease markers, and, hopefully, treatment options, more books like this will be needed to provide clinicians with up-to-date reviews of current practice guidelines.
Meet the Author
Joseph Quinn, MD, Associate Professor of Neurology, Oregon Health and Science University
Dr. Quinn has served as a neurologist clinician in the Oregon Alzheimer's Disease Center since 1994 and has served as Director of the Genetics and Biomarkers Core since 2007.
Dr. Quinn's overall research focus is on developing strategies for treating and preventing Alzheimer's disease and other dementias. Specific research projects range from animal studies testing experimental agents, up to large national multi-center clinical trials of experimental drugs for dementing illnesses. The translation of ideas from the laboratory to the clinic is a particular interest, which is served in part by the Biomarkers core of the Oregon Alzheimer's Center. The Biomarkers Core helps develop blood tests and other disease markers for use in "proof of concept" clinical trials which are necessary to move treatment ideas from animal models to human subjects.
and post it to your social network
Most Helpful Customer Reviews
See all customer reviews >